REGN - Ocular Therapeutix jumps after investor day updates
2024-06-14 12:58:31 ET
More on Ocular Therapeutix
- Ocular Therapeutix: Betting On Axpaxli For A Major Market Breakthrough
- Ocular Therapeutix: Unveiling Pipeline Progress (AXPAXLI, PAXTRAVA) And Q1 Results
- Ocular Therapeutix's Impressive Surge: A Strategic Insight
- Ocular Therapeutix GAAP EPS of -$0.49 misses by $0.29, revenue of $14.77M misses by $0.59M
- Ocular Therapeutix Q1 2024 Earnings Preview